Crystal Magazine Jun 23, 2026
Cinfa and Bahrain Pharmacy & General Store Partner to Expand Access to Trusted Medicines in the Kingdom of Bahrain
As part of its ongoing commitment to improving patient access to high-quality, accessible medicines across the MENA region, Cinfa has partnered with Bahrain Pharmacy & General Store to enter the Kingdom’s healthcare market and further expand its regional footprint.
Cinfa’s entry into the Kingdom of Bahrain is particularly timely, given the challenges posed in the country by cardiovascular disease, which remains one of the leading causes of death in the country, with a reported incidence of 1,284 cases per 100,000 people annually as of 2021 onwards. The company aims to support improved patient access to reliable, accessible treatments aligned with such local healthcare needs.
“Our expansion into the Kingdom of Bahrain marks an important step in our commitment to improving patient access to trusted, accessible medicines across the region. By working closely with local partners like Bahrain Pharmacy & General Store, one of the oldest and most reputable pharmaceutical distributors, we aim to support the management of prevalent conditions such as cardiovascular disease and its key risk factors, including hypertension and high cholesterol,” said Franc Vives, Chief International Officer at Cinfa Group.
“At Bahrain Pharmacy, we strive to provide the Kingdom with the best and most accessible healthcare solutions from around the world. The introduction of Cinfa marks another milestone in our portfolio”, said Dr. Abdulmajeed Alawadhi, CEO of Bahrain Pharmacy.
Through its local partnership in the Kingdom with Bahrain Pharmacy & General Store, Cinfa will introduce a portfolio of medicines aligned with Bahrain’s key healthcare priorities. This includes treatments such as antihypertensives, anti-infectives, therapies for gastroesophageal reflux disease (GERD), and medications addressing men’s health, supporting broader patient access to quality, cost-effective care.
Since establishing its regional presence in the UAE in 2013, the company has focused on bringing trusted medicines and pharmaceutical expertise to patients across the Middle East, ensuring access to quality treatments for both common and chronic conditions. Its portfolio addresses key therapeutic areas including cardiovascular health, infections, pain management, and men’s health.
